Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance

Area of Science:

• Oncology
• Metabolic pathways
• Cancer biology

Background:

• Glucose metabolic reprogramming is increasingly recognized for its role in breast cancer progression, metastasis, and therapy resistance.
• Recent studies have elucidated molecular mechanisms linking glucose metabolism to breast cancer regulation.

Purpose of the Study:

• To review the roles and mechanisms of glucose metabolic reprogramming in breast cancer.
• To summarize metabolic inhibitors targeting glucose metabolism for breast cancer treatment.
• To discuss challenges and opportunities in targeting glucose metabolism for breast cancer therapy.

Main Methods:

• Literature review of studies on glucose metabolism in breast cancer.
• Analysis of molecular mechanisms driving metabolic reprogramming.
• Summary of current metabolic inhibitors and clinical trial status.

Main Results:

• Glucose metabolic reprogramming significantly impacts breast cancer progression, metastasis, and drug resistance.
• Several molecular mechanisms underlying this reprogramming have been identified.
• No drugs specifically targeting glucose metabolism pathways are currently approved for breast cancer treatment.

Conclusions:

• Understanding glucose metabolic reprogramming is crucial for breast cancer treatment.
• Metabolic inhibitors targeting glucose pathways show promise but require further development and clinical validation.
• Overcoming challenges in targeting these pathways presents opportunities for novel breast cancer therapies.